MedTrace Logo

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

NCT07599904 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-07-28

No results posted yet for this study

Summary

Post-Market Registry

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

Mechanical Thrombectomy

Index stroke procedure and follow-up visits up to 90 days post index procedure

Sponsors & Collaborators

  • Medtronic Neurovascular Clinical Affairs

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-13
Primary Completion
2031-07-31
Completion
2031-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07599904 on ClinicalTrials.gov